These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1600387)

  • 1. Immunological adjuvants and their mode of action.
    Allison AC; Byars NE
    Biotechnology; 1992; 20():431-49. PubMed ID: 1600387
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological adjuvants and their modes of action.
    Allison AC
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):141-7. PubMed ID: 9597079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action by immunologic adjuvants.
    Osebold JW
    J Am Vet Med Assoc; 1982 Nov; 181(10):983-7. PubMed ID: 6294032
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of adjuvants that enhance the therapeutic antibody response to host IgE.
    Johansson J; Ledin A; Vernersson M; Lövgren-Bengtsson K; Hellman L
    Vaccine; 2004 Jul; 22(21-22):2873-80. PubMed ID: 15246623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvants: update on concepts].
    Berinstein A; Sadir AM
    Rev Argent Microbiol; 1990; 22(3):159-66. PubMed ID: 2102016
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular adjuvants and immunomodulators: new approaches to immunization.
    Johnson AG
    Clin Microbiol Rev; 1994 Jul; 7(3):277-89. PubMed ID: 7923049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
    Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
    Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial cell surface biological response modifiers and their synthetic counterparts.
    Kotani S
    Adv Exp Med Biol; 1992; 319():145-64. PubMed ID: 1414590
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel adjuvant systems.
    McCluskie MJ; Weeratna RD
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):263-71. PubMed ID: 12455400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of immune responses by muroctasin.
    Akasaki M
    Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
    Tsujimoto M
    J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
    [No Abstract]   [Full Text] [Related]  

  • 14. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of the cytokine inducer romurtide: experimental studies and clinical application.
    Azuma I
    Trends Pharmacol Sci; 1992 Dec; 13(12):425-8. PubMed ID: 1293866
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant effects of saponins on animal immune responses.
    Rajput ZI; Hu SH; Xiao CW; Arijo AG
    J Zhejiang Univ Sci B; 2007 Mar; 8(3):153-61. PubMed ID: 17323426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadjuvants and analogs of immunomodulatory bacterial structures.
    Lise LD; Audibert F
    Curr Opin Immunol; 1989 Dec; 2(2):269-74. PubMed ID: 2696487
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodifiers of bacterial origin.
    Le Garrec Y
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):137-41. PubMed ID: 3791953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant formulations and their mode of action.
    Allison AC; Byars NE
    Semin Immunol; 1990 Sep; 2(5):369-74. PubMed ID: 1966859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Kupffer cell tumoricidal activity by immunomodulators encapsulated in liposomes.
    Daemen T
    Res Immunol; 1992 Feb; 143(2):211-4. PubMed ID: 1574650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.